Carmichael; David F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carmichael; David F..The latest application filed is for "optimized anti-cd30 antibodies".

Company Profile

0.8.15

Carmichael; David F. - Monrovia CA
Carmichael; David F. - Louisville CO
Carmichael, David F. - Pacifica CA
Carmichael; David F. - Boulder CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Optimized anti-CD30 antibodies Grant 9,574,006 - Lazar , et al. February 21, 2	2017-02-21
Modified FC molecules Grant 9,040,041 - Desjarlais , et al. May 26, 2	2015-05-26
Optimized Anti-CD30 Antibodies App 20120014943 - Lazar; Gregory Alan ; et al.	2012-01-19
Optimized anti-CD30 antibodies Grant 7,973,136 - Lazar , et al. July 5, 2	2011-07-05
MODIFIED Fc MOLECULES App 20100249382 - DESJARLAIS; JOHN R. ; et al.	2010-09-30
Pharmaceutical Compositions for the Treatment of TNF-Alpha Related Disorders App 20100222272 - Desjarlais; John R. ; et al.	2010-09-02
Pharmaceutical compositions for the treatment of TNF-.alpha. related disorders Grant 7,662,367 - Desjarlais , et al. February 16, 2	2010-02-16
Optimized Anti-Cd30 Antibodies App 20080267976 - Lazar; Gregory Alan ; et al.	2008-10-30
Fc variants with optimized Fc receptor binding properties App 20080206867 - Desjarlais; John R. ; et al.	2008-08-28
Pharmaceutical compositions for the treatment of TNF-alpha related disorders App 20080187509 - Desjarlais; John R. ; et al.	2008-08-07
Fc Variants With Optimized Fc Receptor Binding Properties App 20070275460 - Desjarlais; John R. ; et al.	2007-11-29
TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS App 20070172449 - Carmichael; David F. ; et al.	2007-07-26
Optimized Anti-cd30 Antibodies App 20070166309 - Lazar; Gregory Alan ; et al.	2007-07-19
Optimized anti-CD30 antibodies App 20070148171 - Lazar; Gregory Alan ; et al.	2007-06-28
Fc Variants With Optimized Fc Receptor Binding Properties App 20070148170 - Desjarlais; John R. ; et al.	2007-06-28
Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same Grant 6,800,732 - Carmichael , et al. October 5, 2	2004-10-05
Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same App 20030003556 - Carmichael, David F. ; et al.	2003-01-02
Connective tissue growth factor (CTGF) and methods of use App 20020142353 - Schmidt, Brian Frederick ; et al.	2002-10-03
Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives App 20020028847 - Stratton, Richard ; et al.	2002-03-07
Method For Treatment Of Fibrosis Related Diseases By The Administration Of Prostacyclin Derivatives App 20010006979 - STRATTON, RICHARD ; et al.	2001-07-05
Method for treating interleukin-1 mediated diseases Grant 6,159,460 - Thompson , et al. December 12, 2	2000-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.